Colombian Candidate's Condition Improves After Being Shot in Head
Miguel Uribe showed a 'favorable and stable' clinical response in recent days, as evidenced by diagnostic imaging and his reaction to surgical and medical interventions, according to a statement Monday by the medical center where he is being treated.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
E&E News
19 minutes ago
- E&E News
Kennedy's MAHA strategy won't be publicly released Aug. 12
Farmers, food manufacturers, chemical companies, anti-vaccine activists and MAHA moms — all waiting anxiously for the release of Health Secretary Robert F. Kennedy Jr.'s strategy for 'making children healthy again' — will have to wait a bit longer. The White House said Monday that it expected the Make America Healthy Again Commission, which President Donald Trump created in February to revamp the nation's food supply and chronic health outcomes, to send the strategy to the president Tuesday, as required by an executive order. However, spokesperson Kush Desai added that it will take more time to coordinate officials' schedules to release the report to the public. Advertisement The upcoming MAHA policy recommendations are expected to suggest a restructuring of the government's response to childhood chronic diseases and will have wide-ranging implications for food, farm and health policy.
Yahoo
27 minutes ago
- Yahoo
Father of CDC gunman indicates possible motivation behind shooting
The man suspected of fatally shooting a police officer and unleashing a barrage of bullets on the U.S. Centers for Disease Control and Prevention (CDC) headquarters in Atlanta on Friday had been fixated on the COVID-19 vaccine, according to the suspect's father. Patrick Joseph White, 30, blamed the COVID-19 vaccine for making him depressed and suicidal, a law enforcement official told the Associated Press on Saturday. The official said White's father had contacted police and identified his son as the possible shooter, telling law enforcement that White had been upset over the death of his dog and had become heavily focused on the COVID-19 vaccine. White also spoke about his distrust of COVID-19 vaccines in unrelated conversations, a neighbor of White's told The Atlanta Journal-Constitution. Death Penalty Possible After 'Random' Hiking Murders Left Children Without Mom And Dad: Former Prosecutor "He was very unsettled, and he very deeply believed that vaccines hurt him and were hurting other people," Nancy Hoalst told the newspaper. "He emphatically believed that." Read On The Fox News App Hoalst said that White "seemed like a good guy" and never believed he would become violent and target the Cdc. The law enforcement official told the AP that White was armed with five guns, including at least one long gun, when the attack unfolded. Bullets hit at least four CDC buildings during the incident, Director Susan Monarez said in a post on X. Images shared by employees showed multiple agency buildings with bullet-pocked windows, underscoring the breadth of the damage to a site where thousands of scientists and staff work on critical disease research. White is also suspected of killing DeKalb County Police Department Officer David Rose, 33, shortly before 5 p.m., the Georgia Bureau of Investigation (GBI) said. Mass Shooting In Baltimore Leaves 6 People Wounded, Including 5-Year-old: Police Other officers found Rose critically wounded at the scene. Rose was rushed to Emory University Hospital where he died from his injuries. Rose, who previously served as a Marine in Afghanistan, graduated from the police academy in March. He is survived by his pregnant wife and two children. The responding officers who found Rose mortally wounded also heard additional gunfire coming from a nearby CVS pharmacy. Officers entered a nearby pharmacy and located the shooter on the second floor with at least one gunshot wound. Atlanta Police Chief Darin Schierbaum said it was not clear if the wound came from police gunfire or if it was self-inflicted. The GBI said the crime scene was "complex" and the investigation would take "an extended period of time." Fox News Digital's Michael Dorgan and Landon Mion, along with the Associated Press, contributed to this article source: Father of CDC gunman indicates possible motivation behind shooting
Yahoo
an hour ago
- Yahoo
‘Remarkable' pancreatic cancer jab offers longer survival hope for patients
A vaccine that appears to slow the progression of one of the most deadly cancers could be manufactured in bulk, researchers say. The jab has given hope to patients after a trial found it increased the survival of participants with pancreatic cancer. Researchers described the findings as 'remarkable' and have already started testing the efficiency of the jab among a larger group of pancreatic and bowel cancer patients. The jab uses a new type of immunotherapy, designed to improve vaccine delivery to the lymph nodes, which help the body fight infections and disease. Pancreatic and bowel cancers frequently carry a mutation in a gene called KRAS, which plays a key role in tumour growth, and scientists developed the jab to recognise and attack this gene. The study, published in the journal Nature Medicine, tested the jab on 20 patients with pancreatic cancer and five with bowel cancer. When participants were followed up after 20 months, 68 per cent had developed strong immune responses specific to mutant KRAS tumour proteins. Participants who had the strongest immune responses lived and stayed cancer-free for longer than those with weaker responses. Some patients survived about two years and five months after receiving the vaccine. In comparison, just three in 10 people diagnosed with pancreatic cancer survive for a year. Pancreatic cancer has some of the poorest survival rates due to late detection. It doesn't usually cause symptoms in the early stages, and as it grows, it can cause tummy pain, yellowing of the skin, unexplained weight loss and changes in stools. Many patients see their cancer returning even after treatments such as radiotherapy and chemotherapy. But the trial showed the jab could help prevent the cancer from returning for more than 15 months. Unlike other cancer jabs which are personalised to individual patients, this vaccine, ELI-002 2P, has a single version which can be given to all patients meaning it can be manufactured in bulk and given more rapidly. Dr Dani Edmunds, research information manager at Cancer Research UK, said: 'It's promising to see that vaccines could help people with pancreatic and bowel cancer live cancer-free for longer.' 'More research is needed to understand why some people benefit from the vaccine while others don't, so that we can make sure we're beating cancer for everyone,' he added. Professor Richard Sullivan, director of the Centre for Conflict and Health Research at King's College London, has suggested more research is needed. 'There is some interesting science in this study, but this is a long way from proving any sort of clinical utility,' he said.
